CatherineEllenMcGuinnMD

Pediatric Hematology & Oncology • New York, NY

Pediatric Coagulation Disorder Hematology

Assistant Professor, Pediatrics, Weill Cornell Medical College

Overview of Dr. McGuinn

Dr. Catherine McGuinn is a pediatric hematologist/oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and New York-Presbyterian Queens. She received her medical degree from New York University Grossman School of Medicine and has been in practice 12 years. Dr. McGuinn accepts several types of health insurance, listed below. She is one of 135 doctors at New York-Presbyterian Hospital and one of 6 doctors at New York-Presbyterian Queens who specialize in Pediatric Hematology & Oncology. She has more than 10 publications and over 500 citings.

Office
525 E 68th St
# Pediatri
New York, NY 10065
Book by Phone+1(217) 600-2343

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2008 - 2011
New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2005 - 2008
New York University School of MedicineClass of 2005

Certifications & Licensure

NY State Medical License 2007 - 2026
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Hemophilia Inhibitor Previously Untreated Patient Study Start of enrollment: 2011 Jul 01
Completed
Safety and Efficacy of Eltrombopag at Escalated Doses Start of enrollment: 2013 Feb 01
Completed
Phase 2
ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP Start of enrollment: 2013 Aug 01
Completed
Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors Start of enrollment: 2019 Jan 30
Completed
Phase 1, Phase 2
Roles: Contact
A Gene Transfer Study for Hemophilia A Start of enrollment: 2017 Jan 26
Completed
Phase 1, Phase 2
Roles: Contact
Emicizumab PUPs and Nuwiq ITI Study Start of enrollment: 2022 Feb 17
Withdrawn
Phase 3
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

453 citations
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant.
Lindsey A. George, Spencer K. Sullivan, Adam Giermasz, John E.J. Rasko, Benjamin J. Samelson-Jones
The New England Journal of Medicine. 2017-12-06
3 citations
A review of the pharmacokinetics, efficacy and safety of high-purity factor X for the prophylactic treatment of hereditary factor X deficiency.
Jeanette Payne, Glaivy Batsuli, Andrew D Leavitt, Mary Mathias, Catherine E McGuinn
Haemophilia. 2022-07-01
15 citations
Long-term safety and efficacy results from the phase 3b, open-label, multicentre Continuation study of rurioctocog alfa pegol for prophylaxis in previously treated pat...
Pratima Chowdary, Eric S. Mullins, Barbara A. Konkle, Catherine E. McGuinn, Young Shil Park
Haemophilia. 2020-06-28

Abstracts/Posters

Efficacy and Safety in 15 Hemophilia B Patients Treated with the AAV Gene Therapy Vector Fidanacogene Elaparvovec and Followed for at Least 1 Year
Catherine E. McGuinn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

A Grandpa's Hope for Hemophilia Cure Leads Him to Gene Therapy Clinical TrialNovember 16th, 2018

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS California CaliforniaCare HMO
BCBS California PowerSelect HMO
BCBS California PPO
BCBS Illinois PPO
BCBS Texas BlueChoice
Blue Shield CA Local Access Plus HMO
Blue Shield California HMO
Blue Shield California PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPO
Great West PPO
Health Net California Large Group PPO
Health Net HMO - Employer Group
Healthfirst New York
HIP of New York - Select PPO
Multiplan PHCS PPO
Multiplan PHCS PPO - Kaiser
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
Pacificare HMO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment